pharma news today obesity drugs glp-1 october 2025 Big in medicine! CMS has announced the BALANCE Model to expand access to obesity medications and support for Medicare/Medicaid populations, and the FDA approved the first oral for weight What's next for GLP-1 innovation:

Event-level analyses of energy drink consumption and alcohol intoxication in bar patrons

You may want to look at our other Bone, Joint and Muscle and GI Health products

Try Setu Skin: Renew FIZZ risk-free with our 60-day money-back guarantee

Despite distinctive ligand recognition and receptor activation mechanisms, the G i -coupling mode of GHSR is highly similar to those of other closely related neuropeptide GPCRs such as neurotensin receptors (NTSRs) 42

Joffre, Reduction of acute mild stress corticosterone response and changes in stressresponsive gene expression in male Balb/c mice after repeated administration of a Rhodiola rosea L

A hub that embraces feedbackcollecting suggestions and publishing changelogsdemonstrates accountability